Previous Close | 0.0003 |
Open | 0.0003 |
Bid | 0.0002 x 0 |
Ask | 0.0003 x 0 |
Day's Range | 0.0002 - 0.0003 |
52 Week Range | 0.0002 - 0.0014 |
Volume | |
Avg. Volume | 20,947,071 |
Market Cap | 369,519 |
Beta (5Y Monthly) | 0.25 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0000 |
Earnings Date | Jun 25, 2020 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
LAS VEGAS, Oct. 29, 2024 (GLOBE NEWSWIRE) -- via IBN -- Due to a website maintenance error, a draft of a letter to BioAdaptives® (OTC: BDPT) shareholders was made available on the BioAdaptives® website. While the timing was unfortunate, it raised awareness of an upcoming event critical for the long-term health of BioAdaptives®. On Jan. 1, 2020, BioAdaptives® had 18,576,379 shares of common stock issued and outstanding. Then, stock was traded for funding to raise money to develop business plans,
We are confident that Gimhana’s leadership will significantly enrich our board’s talent and expertise, propelling us to new heights. LAS VEGAS, May 30, 2024 (GLOBE NEWSWIRE) -- via IBN -- BioAdaptives, Inc. (OTC: BDPT), a leader in the health and wellness sector, today announces the appointment of Gimhana Dissanayake to its Board of Directors. Gimhana, who currently serves as the vice president of operational sales for North America at The Hertz Corporation (NYSE: HTZ), brings over two decades o